Allenamento della forza con manovella eccentrica nei para-atleti (KREHA-ParAth)
The new training device, the eccentric arm-crank, will be examined for its training effects in athletes with a spinal cord injury (SCI) by this project. That the training device can be used in patients with paraplegia in the future, the so-called "testing of the applicability of this concept" will be carried out during this study. Fourteen volunteer, healthy athletes with SCI are first tested for their upper body performance, followed by a training phase over 20 trainings and at the end the performance data is collected again. The training intensity and duration is continuously increased during the training phase.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
At the beginning, the study design includes a familiarisation appointment with performance tests and training on the eccentric arm-crank device (KREHA). At least one week later, the first test sequence including a maximum strength test (bench press) and a test to determine the anaerobic performance (Wingate test) is conducted. The second test sequence takes place one to three days later. This includes a handgrip strength test, an aerobic endurance test (ramp test on the arm crank ergometer with ergospirometry) and a further familiarisation training on the KREHA. The training phase starts within two weeks after the pre-tests have been completed. There are two to a maximum of three trainings per week. These take 30 to 45 minutes and take place on the KREHA device under the supervision of the study staff. The training phase lasts a maximum of twelve weeks (20 training sessions). The first test sequence is repeated five to eight days after the last workout. The second test sequence takes place at the same time interval as in the pre-tests.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Canton of Lucerne
-
Nottwil, Canton of Lucerne, Svizzera, 6207
- Swiss Paraplegic Centre
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- male or female with traumatic or disease-related SCI
- age between 18 and 50 years
- experience in strength training
- Squad status or at least 4h per week training
- Biceps/triceps function
- healthy(study physician)
- adequately informed and confirmed per signature
Exclusion Criteria:
- findings during anamnesis of study physician
- pregnancy
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Eccentric Training
This Group will train on the KREHA for 20 Trainings |
Over the twenty training sessions, able-bodied participants will exercise on the KREHA device. An arm-crank has to be decelerated, which will be rotated by a prematurely defined revolution rate and training duration. During this intervention a certain power has to be applied. During the whole time of training a continous progression in power and training duration is applied. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Upper body Performance
Lasso di tempo: through study completion, an average of 20 weeks
|
Peak Power - maximal reached power, generated during the 30sec Wingate arm-crank test |
through study completion, an average of 20 weeks
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Endurance Oxygen consumption
Lasso di tempo: through study completion, an average of 20 weeks
|
VO2peak [ml/min/kg] - Basic Endurance test (Ergospirometry, arm-crank) |
through study completion, an average of 20 weeks
|
|
Maximal Workload
Lasso di tempo: through study completion, an average of 20 weeks
|
Wmax [W] - Basic Endurance test (Ergospirometry, arm-crank) |
through study completion, an average of 20 weeks
|
|
Upper body Mean Power
Lasso di tempo: through study completion, an average of 20 weeks
|
Mean Power [W] - Wingate Test (arm-crank) |
through study completion, an average of 20 weeks
|
|
Upper body Power - Time to Peak
Lasso di tempo: through study completion, an average of 20 weeks
|
Time to Peak [s] - Wingate Test (arm-crank) |
through study completion, an average of 20 weeks
|
|
Upper body Fatigue Index
Lasso di tempo: through study completion, an average of 20 weeks
|
Fatigue Index [%]- Wingate Test (arm-crank) |
through study completion, an average of 20 weeks
|
|
Upper body Fatigue Slope
Lasso di tempo: through study completion, an average of 20 weeks
|
Fatigue Slope [W/s] - Wingate Test (arm-crank) |
through study completion, an average of 20 weeks
|
|
1RM bench press
Lasso di tempo: through study completion, an average of 20 weeks
|
One Repetition Maximum (1RM) [kg]- bench press |
through study completion, an average of 20 weeks
|
|
Grip Strength
Lasso di tempo: through study completion, an average of 20 weeks
|
Maximal Force that can be generated by pressing hand towards a fist [N] |
through study completion, an average of 20 weeks
|
|
Upper Arm Circumference
Lasso di tempo: through study completion, an average of 20 weeks
|
Circumference of the upper arm is measured with measuring tape |
through study completion, an average of 20 weeks
|
|
Lower Arm Circumference
Lasso di tempo: through study completion, an average of 20 weeks
|
Circumference of the lower arm is measured with measuring tape |
through study completion, an average of 20 weeks
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Fabian Ammann, MSc, SPZ
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 2022-06
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .